| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 108.14 Million |
| Market Size (2030) | USD 125.37 Million |
| CAGR (2025 - 2030) | 3.00 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Brazil Cardiac Pacemakers Market Analysis
The Brazil Cardiac Pacemakers Market size is estimated at USD 108.14 million in 2025, and is expected to reach USD 125.37 million by 2030, at a CAGR of 3% during the forecast period (2025-2030).
Cardiac pacemakers are important devices that help control heart rhythms, especially for patients with conditions like bradycardia or heart block. In Brazil, the market for cardiac pacemakers is growing due to the increasing number of cardiovascular diseases, better healthcare systems, more awareness and heart health programs, and new technologies like MRI-compatible models and remote monitoring features.
The growing number of cardiovascular diseases (CVDs) is a major factor driving the market. For example, an article from the American Heart Association Journal in August 2022 reported that noncommunicable diseases make up 72% of all health cases in Brazil, with about one-third caused by CVDs. The main CVDs in Brazil include myocardial infarction (23.9%), stroke (14.1%), and heart failure (8.9%). Pacemakers help manage these conditions by controlling the heart's electrical activity, reducing symptoms, and improving patients' lives. As more people need cardiac care, the demand for pacemakers increases, leading to innovation and market growth in Brazil.
Also, the risk of heart diseases rises with age. Aging causes changes in the heart and blood vessels, making older people more likely to have conditions like coronary artery disease, heart failure, and arrhythmias, which can lead to cardiac arrest. According to the data published by the Brazilian Institute of Geography and Statistics in August 2024, the group aged 60 and over represented 15.6% of the Brazilian population in 2023 and is expected to reach nearly 38.0% of population by 2070. As Brazil's aging population grows, the need for treatments like cardiac pacemakers also increases, helping the market grow.
In addition, government programs that support affordable and advanced healthcare, such as subsidies for cardiac treatments, make it easier for patients to access modern pacemakers. This better access increases the number of patients using pacemakers and encourages companies to create more affordable and advanced technologies. For example, in April 2022, the Administrative Council for Economic Defense (CADE) made a cease-and-desist agreement with St Jude Medical Brasil (SJM) after investigating a cartel in public procurement. This agreement showed stronger regulations and efforts to ensure fair competition in the pacemaker market, which can build trust and grow the market. By stopping unfair practices, the agreement also helps create more affordable and innovative solutions for patients, increasing the demand for cardiac devices in Brazil.
With the rising number of heart diseases, an aging population, and government efforts to promote affordable healthcare, the market is expected to grow in the coming years. However, high costs of use and maintenance, along with cybersecurity risks in connected pacemakers, may slow down this growth.
Brazil Cardiac Pacemakers Market Trends
The Single Chamber Segment is Expected to Show Significant Growth Over the Forecast Period
The single chamber cardiac pacemakers segment encompasses devices designed to regulate heart rhythms by stimulating either the right atrium or ventricle, primarily used for patients with bradycardia. The segmental growth is mainly driven by its advantages such as lower costs and simplified implantation procedures, making it an attractive option for patients with specific cardiac conditions. Additionally, the increasing prevalence of heart diseases and a growing aging population in Brazil are contributing to the rising demand for single-chamber pacemakers.
Brazil's aging population is driving an increased demand for cardiac devices. Demographic studies indicate a rapid growth in the proportion of elderly individuals in Brazil, leading to a surge in age-related cardiac issues and subsequently boosting the market for single-chamber pacemakers. For instance, an article published in Elsevier in September 2024 highlighted the public health concerns arising from Brazil's growing elderly demographic, especially the uptick in cardiometabolic conditions. Furthermore, data from the Brazilian Institute of Geography and Statistics in August 2024 revealed that approximately 75.3 million Brazil's population will be aged 60 and over by 2070 an increase of 128.2% from 2023. As this demographic becomes increasingly vulnerable to cardiac issues like arrhythmias and heart block, the demand for single-chamber cardiac pacemakers rises, given their essential role in managing these conditions. As a result, healthcare systems are poised to prioritize pacemaker solutions to address the growing prevalence of age-related cardiac challenges.
Furthermore, increasing collaboration between government organisations and hospitals is anticipated to drive the segmental growth in Brazil, significantly enhancing treatment options for patients with heart conditions. For instance, in November 2024, Children's HeartLink established a new partnership with Instituto Nacional de Cardiologia (INC), a hospital in Brazil to enhance pediatric cardiac care globally. This initiative is expected to boost the demand for single chamber cardiac pacemakers in Brazil, facilitating advancements in treatment options for children suffering from heart conditions. Therefore, the implantable single-chamber cardiac pacemaker segment in Brazil is expected to show significant growth in the coming years.
In conclusion, Brazil's aging population, coupled with strengthened collaborations between government bodies and hospitals, is driving innovation and improving access to healthcare technologies like single chamber cardiac pacemakers. This synergy is fuelling the demand for advanced cardiac care solutions, propelling the pacemaker market forward.
Understand The Key Trends Shaping This Market
Download PDF
The External Segment is Expected to Hold a Significant Share of the Market Over the Forecast Period
External cardiac pacemakers are portable devices that temporarily connect to a patient's chest using adhesive electrodes on the skin. They provide electrical signals to the heart when needed.
External pacemakers are non-invasive, easy to adjust, and cost-effective. These benefits are expected to increase their use compared to implantable pacemakers. For example, an article from StatPearls Journal in September 2022 stated that external pacing is the fastest way to restore normal heart rhythm in all bradyarrhythmias, as recommended by the American Heart Association (AHA). This temporary method helps maintain heart function in cases where a permanent pacemaker is needed or in situations where permanent pacing is not suitable.
Chagas disease is a parasitic infection that can damage the heart and cause bradycardia (slow heart rate). The high number of Chagas disease cases in Brazil is expected to increase the use of external pacemakers, as they are often used to treat bradycardia in these patients. For example, a February 2023 article from the Scientific Electronic Library Online (SciELO) reported that 1.9 to 4.6 million people in Brazil have Chagas disease, with Bahia having the highest number of cases.
Similarly, an April 2023 article in the Journal of Parasitologia noted that Chagas disease is common in Latin America, with Brazil having one of the highest rates. The same source reported that Brazil has about 1.2 million new cases each year. This high number of cases is expected to increase the demand for external cardiac pacemakers to treat bradycardia.
In summary, the benefits of external cardiac pacemakers over implantable ones and the high number of Chagas disease cases in Brazil are expected to drive growth in this segment during the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
Brazil Cardiac Pacemakers Industry Overview
The Brazil cardiac pacemakers market is consolidated due to a few large companies dominating the majority of market share, including Abbott, BIOTRONIK, Medtronic, Boston Scientific Corporation, and Osypka Medical, among others. Companies are focusing on strategic partnerships and collaborations to enhance their product offerings and expand market reach. They are also investing in technological advancements to develop innovative and patient-centric solutions, such as remote monitoring capabilities.
Brazil Cardiac Pacemakers Market Leaders
-
LivaNova plc
-
Abbott Laboratories
-
BIOTRONIK SE & Co.KG
-
Medtronic plc
-
Boston Scientific Corporation
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Brazil Cardiac Pacemakers Market News
- November 2024: BIOTRONIK showcased its cutting-edge solutions for treating cardiac arrhythmias at the 41st Brazilian Congress of Cardiac Arrhythmias (SOBRAC 2024). Notably, they have unveiled the sole Physiological Cardiac Pacing technology, recently greenlit by the Brazilian Health Regulatory Agency. This year's SOBRAC occurred in Curitiba from October 31 to November 2, 2024.
- April 2023: The international medical technology company Biotronik Comercial Médica acknowledged its involvement in a cartel that manipulated public bids for high-technology medical supplies in Brazil's cardiac pacemaker market. The admission highlighted the significant ethical and legal concerns within the industry. This development may prompt regulatory scrutiny and impact the competitive landscape for medical technology providers in Brazil.
Brazil Cardiac Pacemakers Industry Segmentation
As per the scope of the report, cardiac pacemakers are medical devices used to deliver electrical pulses to the heart to maintain a normal heart rate. Pacemakers are used to treat patients suffering from heart conditions, such as heart failure and arrhythmias. The Brazil cardiac pacemakers market is segmented by type into implantable and external type. The implantable type is further segmented into single chamber, dual chamber, and biventricular. The report offers the value (in USD) for the above segments.
| By Type | Implantable | Single Chamber |
| Dual Chamber | ||
| Biventricular | ||
| External |
Need A Different Region or Segment?
Customize Now
Brazil Cardiac Pacemakers Market Research FAQs
How big is the Brazil Cardiac Pacemakers Market?
The Brazil Cardiac Pacemakers Market size is expected to reach USD 108.14 million in 2025 and grow at a CAGR of 3% to reach USD 125.37 million by 2030.
What is the current Brazil Cardiac Pacemakers Market size?
In 2025, the Brazil Cardiac Pacemakers Market size is expected to reach USD 108.14 million.
Who are the key players in Brazil Cardiac Pacemakers Market?
LivaNova plc, Abbott Laboratories, BIOTRONIK SE & Co.KG, Medtronic plc and Boston Scientific Corporation are the major companies operating in the Brazil Cardiac Pacemakers Market.
What years does this Brazil Cardiac Pacemakers Market cover, and what was the market size in 2024?
In 2024, the Brazil Cardiac Pacemakers Market size was estimated at USD 104.90 million. The report covers the Brazil Cardiac Pacemakers Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Brazil Cardiac Pacemakers Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
